Jump to content
helplinedonate
Sign in to follow this  
drdanielmtz

Entacapona sin riesgo cardiovascular

Recommended Posts

Una revisión de la FDA no encontró evidencia clara de un aumento de riesgo en ataques al corazón, de embolias cerebrales u otros eventos cardiovasculares asociados con el uso de entacapona para el tratamiento del Parkinson.

 

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm469162.htm

 

La entacapona que puede encontrarse como Comtan o junto con carbidopa/levodopa como Stalevo, puede seguir utilizándose con las mismas recomendaciones. 

 

Saludos,

 

DMR

Twitter: @drdanielmtz

Edited by drdanielmtz
  • Like 1

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
Sign in to follow this  

×
×
  • Create New...